Brief: Venus Remedies Receives Saudi FDA Approval For Plerixafor
22/05/2026 07:29
May 22 (Reuters) - Venus Remedies Ltd VENR.NS: VENUS REMEDIES LTD - RECEIVES SAUDI FDA APPROVAL FOR PLERIXAFOR Source text: ID:nBSE70d2Vj Further company coverage: VENR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage